EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The future of diagnosis in mental health: Promises and challenges of biomarkers to identify reliable and highly predictive biosignatures of affective disorders

Alessandra Berry iD, Mario Luciano iD, Francesca Cirulli iD, Andrea Fiorillo iD

European Psychiatry · 2025 · 68 (1)

DOI: 10.1192/j.eurpsy.2025.15 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Psychiatry, online erschienen am 06.02.2025. Verfasst von Alessandra Berry und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Behavioral Sciences and Mental Health, Istituto Superiore di Sanità, Rome, Italy. Hauptthemen laut MEDLINE: Biomarkers, Major Depressive Disorder, Bipolar Disorder, Mood Disorders. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current evidence points to a research-practice gap in mental health. There is a specific unmet need to identify novel strategies to improve diagnostic criteria, especially when clinical manifestations overlap as in the case of bipolar (BD) and major depressive disorder (MDD). Based on the rapidly evolving notion that affective disorders are characterized by disrupted brain-body communication, current efforts of neuropsychiatric research are converging towards the identification of specific clusters of peripheral interconnected biomarkers. We argue that these can capture the complexity of the disease as they are linked to the fundamental pathophysiological mechanisms underlying BD or MDD, and can thus deliver an unbiased biosignature. Here we provide a critical viewpoint on the promises and challenges of biomarkers to identify reliable biosignatures of affective disorders. Novel methodological insight and relevant biomarkers are discussed with a main focus on immunometabolic derangements and disrupted redox balance. Major advancements are reviewed taking into consideration that an unbiased diagnosis can only derive from a deep understanding of how biological, psychological, and social factors interact ultimately affecting the clinical manifestation of affective disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersMajor Depressive DisorderBipolar DisorderMood DisordersHumans

Stichwörter der Autor:innen

Affective disordersBiomarkersInflammationMetabolismOxidative stress

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Center for Behavioral Sciences and Mental Health, Istituto Superiore di Sanità, Rome, Italy.
  • Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.

ORCID-Profile: Alessandra Berry, Mario Luciano, Francesca Cirulli, Andrea Fiorillo

Zitieren

APA

Berry, A., Luciano, M., Cirulli, F., & Fiorillo, A. (2025). The future of diagnosis in mental health: Promises and challenges of biomarkers to identify reliable and highly predictive biosignatures of affective disorders. European Psychiatry, 68(1). https://doi.org/10.1192/j.eurpsy.2025.15

Vancouver

Berry A, Luciano M, Cirulli F, Fiorillo A. The future of diagnosis in mental health: Promises and challenges of biomarkers to identify reliable and highly predictive biosignatures of affective disorders. European Psychiatry. 2025;68(1). doi:10.1192/j.eurpsy.2025.15

BibTeX
@article{Berry2025,
  author = {Berry, Alessandra and Luciano, Mario and Cirulli, Francesca and Fiorillo, Andrea},
  title = {The future of diagnosis in mental health: Promises and challenges of biomarkers to identify reliable and highly predictive biosignatures of affective disorders},
  journal = {European Psychiatry},
  year = {2025},
  volume = {68},
  number = {1},
  doi = {10.1192/j.eurpsy.2025.15}
}
Kostenlos starten →